Member Info for Kisp57

I phoned HL and they were aware of the problem. The ADIG registrar had requested info from HL which they have supplied,so it is a waiting game I'm afraid.

Still not received in HL

Likewise. I have been in touch with HL and they say they are chasing the registrar.

Looks like it...very poor form

A shocking state of affairs

Nor in HL

It was hoped a distribution would be made on or around the 13th,but the Andean sif sale has been delayed,so presumably a distribution will be made when that completes.

You were spot on...but SP still at a substantial 35-40% discount. Barring any further nasties,there's still value here.

You were spot on...but SP still at a substantial 35-40% discount. Barring any further nasties,there's still value here.

Nav now 29.95p at 31/12/25 so only 2p left in it

Is anyone surprised? Liebour have always robbed the thrifty to pay for the feckless! Twas ever thus.

HL and I'm sure other platforms make it very simple to take up your rights or sell them.

Worth noting is that the next 2 dividends will be 6% higher,so if you take up your rights you'll have more shares earning a higher dividend.

The deal sounds good and should propel us into the Ftse 250 which will force index funds to buy.

HL automatically convert any foreign dividend into sterling.

The market hates loss making acquisitions and margin compression,plus execution risk. We won't know if this acquisition is any good until 2026 results in 2 years. It all adds to the uncertainty,so market reaction is entirely logical.

Someone's keen...no surprise at these prices. The finals are going to be good,and hopefully we will see how Q1 is shaping up.

You highlighted Orphs potential very well I thought given the constraints. In many years of investing,I don't remember a more exciting stock. I am amazed,given the known strings to its bow,that ii's haven't been buying in droves. Then again they are often late to the party and want cold hard cash rather than potential.

Good presentation ,though I don't think your two colleagues really understood the scale of the opportunity here. This is not a pure covid play. Investment in the vaccine space will be multi year or multi decade. And with "data is the new gold" ,disease in motion could become a billion dollar company in its own right.

It is not the GM's job to keep commenting on share price movements. It is his job to build the business,and the share price will look after itself. Focussing on day to day price swings won't be good for anyone's sanity. I agree that we are ridiculously oversold,but the market will eventually come to its senses. A good time to build your stake if you truly believe in the company.

Hopefully this crazy vanity deal will depart with Felix.

I agree. I would much rather a special dividend from the cash generated during the pandemic period, instead of paying it to Tastytrade (what a ridiculous name) shareholders.